Gogas, H.; Dummer, R.; Ascierto, P. A. et al.
Quality-of-life (QoL) in COLUMBUS part 1: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) versus vemurafenib (VEM) or ENCO in braf-mutant melanomaANNALS OF ONCOLOGY. Bd. 28. 2017
Berking, Carola; Ascierto, Paolo A.; Gogas, Helen J. et al.
Quality-of-Life (QoL) in COLUMBUS Part 1: A Phase 3 Trial of Encorafenib (ENCO) Plus Binimetinib (BINI) Versus Vemurafenib (VEM) or ENCO in BRAF-Mutant MelanomaJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 15. 2017 S. 45-45
Schultheis, M.; Geppert, C.; Weustenfeld, C. et al.
Rapid Improvement of tumor-related Renal Insufficiency based on BRAF-/MEK-Inhibitor TherapyJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 15. 2017 S. 51-51
Pohlit, H.; Bellinghausen, I.; Frey, H. et al.
Recent advances in the use of nanoparticles for allergen-specific immunotherapyALLERGY. Bd. 72. H. 10. 2017 S. 1461-1474
Henning, B.; Bradfisch, F.; Stege, H. et al.
Recurrent CK-Increase in a 28-year-old Patient with metastatic malignant Melanoma by BRAF/MEK Therapy and Immune Checkpoint-Inhibitors TherapyJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 15. 2017 S. 33-34
Haeberle, Stefanie; Raker, Verena; Haub, Jessica et al.
Regulatory T cell deficient scurfy mice exhibit a Th2/M2-like inflammatory response in the skinJOURNAL OF DERMATOLOGICAL SCIENCE. Bd. 87. H. 3. 2017 S. 285-291
Juchems, E.; Grabbe, S.; Schopf, R. E. et al.
Relevance of a peritherapeutic Ultrasound Examination in infantile Hemangioma during pulsed-dye Laser TherapyMONATSSCHRIFT KINDERHEILKUNDE. Bd. 165. H. 4. 2017 S. 325-332
Ohanyan, Tatevik; Schoepke, Nicole; Bolukbasi, Bediha et al.
Responsiveness and minimal important difference of the urticaria control testJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Bd. 140. H. 6. 2017 S. 1710-+
Dummer, Reinhard; Ascierto, Paolo A.; Gogas, Helen J. et al.
Results of COLUMBUS Part 2: A Phase 3 Trial of Encorafenib (ENCO) Plus Binimetinib (BINI) Versus ENCO in BRAF - Mutant MelanomaJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 15. 2017 S. 12-13
Dummer, R.; Ascierto, P. A.; Gogas, H. et al.
Results of COLUMBUS Part 2: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) versus ENCO in BRAF-mutant melanomaANNALS OF ONCOLOGY. Bd. 28. 2017